Compound Detail
CHEMBL4643300
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Cc1ccc(CN2CCN(C)CC2)n1-c1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)C)ccc32)c2ccccc2)cc1
Basic Information
| ChEMBL ID | CHEMBL4643300 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | ZSHOZEYKPGNSGI-KARKAFJISA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
574.7
MW (Da)
5.17
ALogP
6
HBA
2
HBD
72.8
PSA (Ų)
0.30
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 7.19
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 7.19 | 7.19 | 65.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Vascular endothelial growth factor receptor 2 | IC50 | = | 65.0 | nM | 7.19 | Inhibition of N-terminal GST fused human VEGFR2 cytoplasmic domain (790 to 1356 ... | 32305182 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32305182 | 10.1016/j.bmc.2020.115486 | Vascular endothelial growth factor receptor 2 | 1 |
| 32305182 | 10.1016/j.bmc.2020.115486 | Platelet-derived growth factor receptor beta | 1 |
Data from ChEMBL 36 via Core Engine